Author: Zaudig M.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.23, Iss.3, 2000-09, pp. : 183-195
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risperidone for behavioural and psychological symptoms of dementia
Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. :
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
By Vitezic D.
Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. :
A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis
Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. :